Windsor Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Windsor Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$257K	Sell	4,436 -96	-2%	-$5.88K	0.05%	133
2023 Q2	$290K	Sell	4,532 -139	-3%	-$9.32K	0.05%	131
2023 Q1	$328K	Hold	4,671	–	–	0.06%	122
2022 Q4	$341K	Sell	4,671 -26	-0.6%	-$1.96K	0.07%	116
2022 Q3	$327K	Buy	4,697 +23	+0.5%	+$1.67K	0.08%	109
2022 Q2	$356K	Sell	4,674 -4,601	-50%	-$350K	0.09%	107
2022 Q1	$721K	Sell	9,275 -175	-2%	-$11.8K	0.13%	128
2021 Q4	$587K	Sell	9,450 -516	-5%	-$30.3K	0.11%	143
2021 Q3	$593K	Buy	9,966 +30	+0.3%	+$1.98K	0.12%	142
2021 Q2	$664K	Sell	9,936 -1,026	-9%	-$66.9K	0.14%	134
2021 Q1	$692K	Buy	10,962 +952	+10%	+$59.2K	0.16%	117
2020 Q4	$621K	Sell	10,010 -92	-0.9%	-$5.66K	0.16%	121
2020 Q3	$603K	Sell	10,102 -709	-7%	-$42.7K	0.18%	112
2020 Q2	$636K	Buy	10,811 +472	+5%	+$28.2K	0.2%	104
2020 Q1	$576K	Sell	10,339 -386	-4%	-$23.6K	0.23%	101
2019 Q4	$688K	Buy	10,725 +5,054	+89%	+$289K	0.25%	93
2019 Q3	$279K	Buy	+5,671	New	+$267K	0.12%	148
2019 Q2	–	Sell	-4,819	Closed	-$230K	–	176
2019 Q1	$230K	Sell	4,819 -722	-13%	-$36K	0.13%	137
2018 Q4	$288K	Sell	5,541 -2,470	-31%	-$133K	0.2%	111
2018 Q3	$497K	Buy	8,011 +2,006	+33%	+$119K	0.32%	85
2018 Q2	$332K	Sell	6,005 -2,220	-27%	-$120K	0.26%	98
2018 Q1	$520K	Buy	8,225 +1,295	+19%	+$83.3K	0.44%	61
2017 Q4	$425K	Buy	+6,930	New	+$433K	0.37%	70

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Windsor Wealth Management's BMY Position: Q3 2023 in Review

Windsor Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 2.1% in Q3 2023, selling an estimated $5.88K and leaving 4,436 shares worth $257K. The position accounts for 0.05% of the portfolio, ranked #133.

Windsor Wealth Management first reported a position in BMY in Q4 2017 and has held it in 23 quarters since. The position peaked at $721K in Q1 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Windsor Wealth Management held 4,436 shares of Bristol-Myers Squibb worth $257K as of Q3 2023.
Windsor Wealth Management sold 96 Bristol-Myers Squibb shares in Q3 2023, an estimated $5.88K.
Bristol-Myers Squibb made up 0.05% of Windsor Wealth Management's portfolio in Q3 2023, its #133 holding.
Windsor Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 23 quarters since.
Windsor Wealth Management's Bristol-Myers Squibb position peaked at $721K in Q1 2022.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Windsor Wealth Management's 13F filing for Q3 2023, filed 24 Oct 2023.